STABILE ANTIKÖRPER-FORMULIERUNGEN

European patent · EP2081553 · In force

Register entry

Publication number
EP2081553
Application number
EP07839335
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 5, 2007
Published
Jul 29, 2009
Granted
Aug 12, 2020
Protection ends at the latest
Oct 4, 2027
Next annual fee due
Oct 31, 2027
IPC classes
A61K 9/19 (2006.01)
A61K 47/02 (2006.01)
A61K 47/26 (2006.01)
A61K 9/00 (2006.01)
A61K 39/395 (2006.01)
Priority
US 850362 P 06.10.2006
US 850970 P 10.10.2006
PCT application
PCT/US2007/021477 05.10.2007
PCT publication
WO2008/045373 17.04.2008
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.10.2026 → 31.10.2027

    Published in Swissreg on 01.11.2026

  2. Nov 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.10.2025 → 31.10.2026

    Published in Swissreg on 01.11.2025

  3. Nov 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.10.2024 → 31.10.2025

    Published in Swissreg on 01.11.2024

  4. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  5. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  6. Aug 12, 2020

    Granted

    Published in Swissreg on 12.08.2020

Parties

Holder

Amgen Inc.

One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US

Inventor

REHDER, Douglas

Woodland Hills, CA 91364, US

MCAULEY, Arnold

Moorpark, CA 93021, US

MATSUMURA, Masazumi

Thousand Oaks, CA 91362, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.